TPB - Turning Point Brands... Stock Analysis | Stock Taper
Logo
Turning Point Brands, Inc.

TPB

Turning Point Brands, Inc. NYSE
$136.99 -3.43% (-4.87)

Market Cap $2.61 B
52w High $146.90
52w Low $51.48
Dividend Yield 0.29%
Frequency Quarterly
P/E 42.15
Volume 360.92K
Outstanding Shares 19.07M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $118.98M $44.54M $21.08M 17.72% $1.16 $39.12M
Q2-2025 $116.63M $40.3M $14.48M 12.41% $0.81 $30.13M
Q1-2025 $106.44M $36.42M $14.39M 13.52% $0.81 $24.98M
Q4-2024 $93.67M $34.53M $2.42M 2.58% $0.14 $23.93M
Q3-2024 $90.7M $29.59M $12.38M 13.64% $0.7 $23.61M

What's going well?

Profits jumped sharply, and gross margins improved, showing the company is keeping more from each sale. Revenue is steady, and there were no big one-time charges.

What's concerning?

Operating expenses are rising faster than sales, which could hurt future profits if not controlled. Share dilution is creeping up, and interest costs remain a drag.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $201.19M $742.85M $384.69M $343.95M
Q2-2025 $109.92M $595.79M $370.96M $218.58M
Q1-2025 $99.64M $564.55M $361.12M $199.69M
Q4-2024 $46.16M $493.35M $302.97M $187.98M
Q3-2024 $33.56M $488.01M $301.25M $185.67M

What's financially strong about this company?

TPB has a strong cash position, easily covers its bills, and has increased shareholder equity. Most debt is long-term, and the company is buying back shares, showing confidence.

What are the financial risks or weaknesses?

Inventory has grown quickly, which could mean slower sales or excess stock. A sizable portion of assets is goodwill and intangibles, which could be written down if acquisitions disappoint.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $23.76M $3.29M $-19.76M $107.94M $91.26M $-721K
Q2-2025 $16.96M $11.82M $-3.4M $1.79M $10.29M $7.83M
Q1-2025 $14.39M $17.41M $-5.23M $38.52M $50.65M $15.22M
Q4-2024 $10.57M $17.74M $-1.45M $-757K $15.39M $16.63M
Q3-2024 $12.44M $13.24M $-1.09M $-120.78M $-108.58M $12.59M

What's strong about this company's cash flow?

The company now has a large cash cushion of $203 million, giving it flexibility for the near term. Net income remains positive, and there is no new debt.

What are the cash flow concerns?

Cash from operations dropped sharply, and free cash flow turned negative. The company is highly dependent on raising money from selling new shares, which dilutes current shareholders.

Revenue by Products

Product Q1-2024Q2-2024Q2-2025Q3-2025
Stokers Products
Stokers Products
$40.00M $40.00M $70.00M $70.00M
ZigZag Products
ZigZag Products
$50.00M $50.00M $0 $0

Revenue by Geography

Region Q1-2024Q2-2024Q2-2025Q3-2025
NonUS
NonUS
$10.00M $10.00M $10.00M $10.00M
UNITED STATES
UNITED STATES
$90.00M $100.00M $110.00M $110.00M

Q3 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Turning Point Brands, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key strengths include improving profitability and solid cash generation, a materially de-risked balance sheet with lower leverage, and a portfolio of well-known brands supported by a broad distribution network. The company has demonstrated the ability to recover margins after a difficult year, convert earnings into cash, and use that cash to strengthen its financial position. Its focus on non-cigarette categories and modern oral products positions it in parts of the nicotine market that still have room to grow, while legacy products provide a stable base of cash flow to fund innovation and shareholder returns.

! Risks

The main risks are revenue volatility, rising overhead, and a thinner cash buffer following substantial debt repayment. The business operates in heavily regulated categories where policy shifts can be abrupt and material. Competition in modern oral and other alternative products is intense, with much larger players investing heavily. Innovation efforts—such as onshoring production and expanding the sales force—require upfront spending and operational execution, which could pressure margins or create hiccups if not well managed. Finally, the modest level of formal R&D and reliance on marketing- and distribution-led differentiation may limit the company’s ability to stay ahead if the industry’s technology or regulatory bar rises quickly.

Outlook

Overall, TPB appears to be transitioning from a more leveraged, acquisition-tilted story to a leaner, cash-generative operator focused on modern oral and other alternative products. With margins trending higher, free cash flow solid, and debt reduced, the financial foundation is sturdier than a few years ago, though liquidity needs monitoring. The forward picture will likely hinge on two things: the success of its modern oral and other growth initiatives, and the trajectory of regulation in its key categories. If the company can execute its innovation and distribution plans while keeping costs in check and navigating regulation, its recent improvements in profitability and cash flow could be sustainable; if not, the combination of revenue volatility and a smaller cash cushion could reintroduce pressure into the story.